Mahzi Therapeutics announces FDA rare pediatric disease Designation for MZ-1866 investigational therapy for Pitt Hopkins syndrome PR Newswire (Press Release) 3h PR Newswire (Press Release) 3h
Airway Therapeutics closes $50 million equity round to advance late-stage development of zelpultide alfa PR Newswire (Press Release) 4h PR Newswire (Press Release) 4h
Talks on Skyclarys have reached a critical point – David Cullinane TD Sinn Féin (Press Release) 1d Sinn Féin (Press Release) 1d
Summit's ivonescimab+ chemotherapy shows significant PFS benefit in Phase III harmoni trial RTT News 5h RTT News 5h
OmicsBank Raises $2.25M to Expand Clinical Data Infrastructure Globally for Healthcare, Life Sciences, and Frontier AI Labs PR Newswire (Press Release) 17:27
Quick spark: Nvidia-Backed Biotech Says AI Could Make Biology Programmable Benzinga 17:23 Article paywall
Collegium CEO is moving the biotech firm to Boston from the suburbs Boston Globe 16:38 Article paywall
University of Washington and Seattle biotech win $245M patent judgment against Guardant GeekWire 16:23
Jazz Receives FDA Approval For Ziihera Regimens In First-Line HER2+ Gastroesophageal Cancer RTT News 16:19